JP2006169149A - Epidermal basal cell-growth promoter of skin - Google Patents

Epidermal basal cell-growth promoter of skin Download PDF

Info

Publication number
JP2006169149A
JP2006169149A JP2004362108A JP2004362108A JP2006169149A JP 2006169149 A JP2006169149 A JP 2006169149A JP 2004362108 A JP2004362108 A JP 2004362108A JP 2004362108 A JP2004362108 A JP 2004362108A JP 2006169149 A JP2006169149 A JP 2006169149A
Authority
JP
Japan
Prior art keywords
skin
epidermal basal
basal cell
mangosteen
growth promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004362108A
Other languages
Japanese (ja)
Inventor
Yoshinobu Kato
榮信 加藤
Shinya Hosoda
真也 細田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOSODA SHC KK
Hosoda SHC Inc
Original Assignee
HOSODA SHC KK
Hosoda SHC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOSODA SHC KK, Hosoda SHC Inc filed Critical HOSODA SHC KK
Priority to JP2004362108A priority Critical patent/JP2006169149A/en
Publication of JP2006169149A publication Critical patent/JP2006169149A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To obtain an epidermal basal cell-growth promoter of skin containing an extract of Garcinia mangostana Linne. <P>SOLUTION: The epidermal basal cell-growth promoter of skin contains an extract of Garcinia mangostana Linne. as an active ingredient obtained by immersing fruit of Garcinia mangostana Linne. in water and an organic solvent. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、マンゴスチン抽出物を含有する皮膚表皮基底細胞増殖促進剤に関する。   The present invention relates to a skin epidermal basal cell proliferation promoter containing a mangosteen extract.

皮膚の老化は,肌のたるみ,シミ,シワなどの諸症状をもたらし,紫外線によって著しく促進されるが,その主な原因は紫外線によって生じた活性酸素であると考えられている(香粧品科学,32頁,朝倉書店発行)。このことから,紫外線吸収剤や抗酸化剤に関してのものが多く出願されている。また,最近老化を防ぐ一つの方法としてマトリックスメタロプロテアーゼ阻害剤が特開2003−252745などに開示されている。 Skin aging causes various symptoms such as sagging, spots and wrinkles in the skin, and is significantly accelerated by ultraviolet rays. The main cause is considered to be active oxygen produced by ultraviolet rays (cosmetic science, 32 pages, published by Asakura Shoten). For this reason, many applications have been filed regarding ultraviolet absorbers and antioxidants. Recently, matrix metalloprotease inhibitors have been disclosed in JP-A-2003-252745 as one method for preventing aging.

しかしながら,これらは全て老化を抑制するものであり、皮膚表皮基底細胞を賦活させて細胞増殖促進による皮膚の若々しさ(瑞々しさ)を保つものは見当たらない。
特開2003−252745号公報
However, all of these suppress aging, and none of the skin epidermal basal cells are activated to maintain the youthfulness of the skin by promoting cell proliferation.
JP 2003-252745 A

本発明は、上記問題点に鑑みてなされたものであり、マンゴスチン抽出物を含有する皮膚表皮基底細胞増殖促進剤を提供することを目的とする。   This invention is made | formed in view of the said problem, and it aims at providing the skin epidermal basal cell proliferation promoter containing a mangosteen extract.

本発明者らは、有用な皮膚表皮基底細胞増殖促進剤を得る目的で種々の植物抽出物について皮膚表皮基底細胞増殖促進作用をスクリーニングした結果,マンゴスチン抽出物が皮膚表皮基底細胞増殖促進作用を有することを見出し,本発明を完成するに至った。即ち、本発明は、マンゴスチン抽出物を有効成分として含有することを特徴とする皮膚表皮基底細胞増殖促進剤に関する。   As a result of screening the skin epidermal basal cell proliferation promoting effect on various plant extracts for the purpose of obtaining a useful skin epidermal basal cell proliferation promoting agent, the present inventors have found that the mangosteen extract has a skin epidermal basal cell proliferation promoting action. As a result, the present invention has been completed. That is, the present invention relates to a skin epidermal basal cell proliferation promoter comprising a mangosteen extract as an active ingredient.

本発明によると,食用としているマンゴスチン果実から製造したマンゴスチン抽出物を有効成分とする皮膚表皮基底細胞増殖促進剤は,安全であり,皮膚表皮基底細胞の増殖促進作用を有するので,安心して化粧料,皮膚外用剤及び浴用剤に利用することができる。即ち,皮膚の若々しさを保つことにより,弾力のある,シミ,シワやたるみなどのない肌の維持,湿疹,アトピー性皮膚炎や肌荒れなどの皮膚疾患や創傷の治癒促進などが期待される。   According to the present invention, the skin epidermal basal cell proliferation promoter comprising a mangosteen extract produced from edible mangosteen fruit as an active ingredient is safe and has a proliferation promoting effect on skin epidermal basal cells. , It can be used for skin external preparation and bath preparation. That is, by maintaining the youthfulness of the skin, it is expected to maintain elastic skin without spots, wrinkles or sagging, skin diseases such as eczema, atopic dermatitis and rough skin, and promote healing of wounds. .

本発明で言うマンゴスチン(学名Garcinia mangostana L.)は、タイを原産国とするオトギリソウ科の植物で東南アジア地域に広く栽培され、果肉は甘味と酸味が適度に調和して上品な味で好まれ、果皮はコレラや赤痢の治療、下痢止め、更に中枢神経系鎮静剤や血圧上昇剤として利用されている。使用する果実は、未熟又は完熟の何れでもよく,果実全体及び果皮のことを意味し、乾燥物でも未乾燥(生)でもよく,破砕機で破砕するかスライサーで細断してから用いる。 Mangosteen said by the present invention (scientific name: Garcinia mangostana L.) is a hypericaceae plant originating in Thailand and is widely cultivated in the Southeast Asian region. The pericarp is used as a treatment for cholera and dysentery, to prevent diarrhea, and as a central nervous system sedative and blood pressure increasing agent. The fruit to be used may be either immature or fully ripe, meaning the whole fruit and the fruit skin, which may be dried or undried (raw), and is used after being crushed with a crusher or shredded with a slicer.

本発明において抽出に用いる溶媒は、水及び有機溶媒であり、有機溶媒としては、メタノール、エタノール、プロパノール、ブタノールなどのアルコール類、ヘキサン、ベンゼンなどの炭化水素類、ジエチルエーテルなどのエーテル類、酢酸メチル、酢酸エチルなどのエステル類、アセトンなどのケトン類、塩化メチレン、クロロホルムなどのハロゲン化炭化水素類、酢酸、氷酢酸、プロピオン酸などの常温で液体の有機酸などであり、単一又は混合して用いる。その使用量は、マンゴスチン果実1部に対し1〜50部である。1部以下では抽出物の収量が低くなり、50部以上では溶媒留去に時間がかかるので好ましくない。   The solvent used for extraction in the present invention is water and an organic solvent. Examples of the organic solvent include alcohols such as methanol, ethanol, propanol and butanol, hydrocarbons such as hexane and benzene, ethers such as diethyl ether, acetic acid. Esters such as methyl and ethyl acetate, ketones such as acetone, halogenated hydrocarbons such as methylene chloride and chloroform, organic acids that are liquid at room temperature such as acetic acid, glacial acetic acid and propionic acid, etc., single or mixed And use. The usage-amount is 1-50 parts with respect to 1 part of mangosteen fruit. If it is 1 part or less, the yield of the extract is low, and if it is 50 parts or more, it takes time to distill off the solvent, which is not preferable.

本発明のマンゴスチン抽出物は、次のようにして製造することができる。
未熟なマンゴスチン果実1部(重量)をスライス又は破砕して水1〜50部中で加温処理する。浮遊する黄色の物質を常法により分取して通常の乾燥機で乾燥する。
熟していないマンゴスチン果実或いは熟したマンゴスチン果実又は果皮1部(重量)をスライス又は破砕して含水有機溶媒又は有機溶媒1〜50部中、室温乃至沸騰温度で数時間乃至数日間浸漬し、スライス又は破砕果実又は果皮を濾去する。濾液を常法により常圧又は減圧濃縮後分取するか或いは溶媒留去して通常の乾燥機で乾燥する。
The mangosteen extract of the present invention can be produced as follows.
1 part (weight) of immature mangosteen fruit is sliced or crushed and heated in 1 to 50 parts of water. Floating yellow substance is collected by a conventional method and dried with a normal dryer.
Sliced or crushed 1 part (by weight) of unripe mangosteen fruit or ripe mangosteen fruit or fruit skin, immersed in water-containing organic solvent or 1 to 50 parts of organic solvent at room temperature to boiling temperature for several hours to several days, sliced or Remove the crushed fruit or peel. The filtrate is collected after concentration at normal pressure or reduced pressure by a conventional method, or the solvent is distilled off and dried in a normal dryer.

本抽出物をシリカゲル及び逆相カラムクロマトグラフ法により精製することができる。
本発明で言う加温処理とは、浸漬液を室温以上の温度にすることであり、好ましくは40℃より高い温度で浸漬する操作(工程)を意味する。
The extract can be purified by silica gel and reverse phase column chromatography.
The heating treatment referred to in the present invention is to bring the immersion liquid to a temperature of room temperature or higher, and preferably means an operation (step) of immersion at a temperature higher than 40 ° C.

本発明のマンゴスチン抽出物を有効成分として含有する皮膚表皮基底細胞増殖促進剤は、単独,又は化粧品,皮膚外用剤及び浴用剤に通常使用される成分や添加剤などを配合して化粧料,皮膚外用剤及び浴用剤の製造に用いることができる。その配合量は,0.0001〜50質量%(以下,「%」は「質量%」を意味する),好ましくは0.001〜40%であり,0.0001%以下では十分な効果が得られない。   The skin epidermal basal cell proliferation promoter containing the mangosteen extract of the present invention as an active ingredient is used alone or in combination with ingredients or additives usually used in cosmetics, topical skin preparations and bath preparations. It can be used for the manufacture of external preparations and bath preparations. The blending amount is 0.0001 to 50% by mass (hereinafter, “%” means “% by mass”), preferably 0.001 to 40%. If 0.0001% or less, sufficient effect is obtained. I can't.

通常化粧品,皮膚外用剤及び浴用剤に使用される成分や添加剤の例としては,保湿剤,酸化防止剤,美白剤,紫外線吸収剤,抗炎症剤,殺菌剤,抗アレルギー剤,血流改善剤,界面活性剤,増粘剤,防腐剤,pH調整剤,清涼剤,安定化剤,乳化剤,溶剤,キレート剤,着色料,香料,無機顔料,アルコール類,油脂類,ロウ類,脂肪酸類,エステル類,多糖類,ビタミン類,ホルモン類,酵素,アミノ酸,ペプチド,水,水性成分,粉末成分などが挙げられる。   Examples of ingredients and additives that are commonly used in cosmetics, external skin preparations, and bath preparations include moisturizers, antioxidants, whitening agents, UV absorbers, anti-inflammatory agents, bactericides, antiallergic agents, and blood flow improvement. Agent, surfactant, thickener, preservative, pH adjuster, refresher, stabilizer, emulsifier, solvent, chelating agent, colorant, fragrance, inorganic pigment, alcohol, fats and oils, waxes, fatty acids , Esters, polysaccharides, vitamins, hormones, enzymes, amino acids, peptides, water, aqueous components, powder components, and the like.

本発明の皮膚表皮基底細胞増殖促進剤を用いる化粧料及び皮膚外用剤の例としては,化粧水,乳液,クリーム,軟膏,ローション,オイル,パック,石鹸,シャンプー,ヘアートリートメント,ファンデーション,おしろい,皮膚散布薬などが挙げられる。   Examples of cosmetics and skin external preparations using the skin epidermal basal cell proliferation promoter of the present invention include skin lotion, emulsion, cream, ointment, lotion, oil, pack, soap, shampoo, hair treatment, foundation, funnier, skin Examples include spraying drugs.

以下、本発明を実施例及び試験例により詳細に説明する。
実施例1
未熟マンゴスチン果実835gをスライスした後、水4.6kgに50℃で1時間浸漬した。淡褐色の液中に浮遊する黄褐色物質を濾布で採取し、65℃で乾燥してマンゴスチン抽出物を黄褐色微粉末として9.9g得た。
Hereinafter, the present invention will be described in detail with reference to examples and test examples.
Example 1
After 835 g of immature mangosteen fruit was sliced, it was immersed in 4.6 kg of water at 50 ° C. for 1 hour. A yellowish brown substance floating in the light brown liquid was collected with a filter cloth and dried at 65 ° C. to obtain 9.9 g of a mangosteen extract as a fine yellowish brown powder.

実施例2
熟したマンゴスチン果皮の破砕物173gを65%エタノール500gに加え,60℃で5時間浸漬した。冷後,濾紙濾過し,濾液を減圧濃縮してエタノールを溜去した。濃縮物を遠心して淡黄色の沈降物を分取し、40℃で減圧乾燥してマンゴスチン抽出物を淡黄色微粉末として3.1g得た。
Example 2
173 g of ripened mangosteen peel was added to 500 g of 65% ethanol and immersed at 60 ° C. for 5 hours. After cooling, it was filtered through filter paper, and the filtrate was concentrated under reduced pressure to distill off ethanol. The concentrate was centrifuged to collect a pale yellow precipitate and dried under reduced pressure at 40 ° C. to obtain 3.1 g of a mangosteen extract as a pale yellow fine powder.

実施例3
未熟マンゴスチン果実の細片カット乾燥物3kgを60℃の60%エタノール30kgに一夜浸漬した後,フィルタープレスろ過し,濾液を減圧濃縮してエタノールを溜去した。濃縮物を凍結乾燥してマンゴスチン抽出物を淡黄褐色粉末として810g得た。
Example 3
After 3 kg of dried cut pieces of immature mangosteen fruit were soaked in 30 kg of 60% ethanol at 60 ° C. overnight, they were filtered with a filter press, and the filtrate was concentrated under reduced pressure to distill off the ethanol. The concentrate was lyophilized to obtain 810 g of a mangosteen extract as a light tan powder.

試験例1
ヌードマウスの皮膚を伸展法により分離した表皮を細片化し,現代皮膚科学大系第4巻B検査II実験法(中山書店発行)194〜5頁記載の方法に従って表皮基底細胞の10〜50個の小細胞塊を調製した。本小細胞塊を浮遊させたEagle MEM2mlを60mm径の滅菌シャーレに注入し,30℃の炭酸ガスふ卵器中で24時間培養後,各濃度の実施例1で得られたマンゴスチン抽出物のDMSO溶液を添加したEagle MEM1mlを加えて更に9日間培養した。各シャーレ内に生じたcell sheetの総面積を画像解析装置により測定した。その結果,対照(添加濃度:0%)の総面積を100としたときのマンゴスチン抽出物添加群の総面積は,培地中添加濃度が0.0025%のとき115,0.005%のとき129,0.01%のとき157,0.015%のとき177,0.02%のとき186であった。マンゴスチン抽出物の濃度が増加するに伴って総面積が増え,表皮基底細胞の増殖促進が認められた。
Test example 1
10-50 epidermal basal cells according to the method described in pages 194-5 of Modern Dermatology University Vol. 4 B Test II Experiment Method (published by Nakayama Shoten) Small cell masses were prepared. 2 ml of Eagle MEM in which this small cell mass is suspended is poured into a sterile petri dish with a diameter of 60 mm, cultured in a carbon dioxide incubator at 30 ° C. for 24 hours, and then a DMSO solution of the mangosteen extract obtained in Example 1 at each concentration. 1 ml of Eagle's MEM to which was added was added and further cultured for 9 days. The total area of the cell sheet generated in each petri dish was measured with an image analyzer. As a result, the total area of the mangosteen extract addition group when the total area of the control (addition concentration: 0%) is 100 is 115 when the addition concentration in the medium is 0.0025% and 129 when the addition concentration is 0.005%. , 0.01% for 157, 0.015% for 177, 0.02% for 186. As the concentration of mangosteen extract increased, the total area increased and the proliferation of epidermal basal cells was observed.

試験例2
実施例3で得られたマンゴスチン抽出物の40g,ポリエチレングリコール1000の30g及びカオリンの30gをよく混合して得られる混合物の適量を,肘関節の色素沈着して痒みのある患部に1日1回,7日間塗布した。結果は図1に示すとおり,塗布前には色素沈着が進行している患部の痒みが塗布により消失すると同時に皮膚表皮基底細胞の増殖が促されて色素沈着した角質層の剥離が徐々に始まり,7日後には完全に元の状態に戻り、完治した。
Test example 2
Appropriate amount of the mixture obtained by thoroughly mixing 40 g of the mangosteen extract obtained in Example 3, 30 g of polyethylene glycol 1000 and 30 g of kaolin was once a day on the affected area where the elbow joint was pigmented and itchy. For 7 days. As shown in FIG. 1, the itch of the affected area where pigmentation has progressed before application disappears as a result of application, and at the same time the proliferation of skin epidermal basal cells is promoted, and the exfoliation of the pigmented stratum corneum begins gradually. Seven days later, it completely returned to its original condition and was completely cured.

塗布前後の皮膚患部の変化を示した図Figure showing changes in the affected skin before and after application

Claims (1)

マンゴスチン抽出物からなる皮膚表皮基底細胞増殖促進剤。
A skin epidermal basal cell proliferation promoter comprising a mangosteen extract.
JP2004362108A 2004-12-15 2004-12-15 Epidermal basal cell-growth promoter of skin Pending JP2006169149A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004362108A JP2006169149A (en) 2004-12-15 2004-12-15 Epidermal basal cell-growth promoter of skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004362108A JP2006169149A (en) 2004-12-15 2004-12-15 Epidermal basal cell-growth promoter of skin

Publications (1)

Publication Number Publication Date
JP2006169149A true JP2006169149A (en) 2006-06-29

Family

ID=36670281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004362108A Pending JP2006169149A (en) 2004-12-15 2004-12-15 Epidermal basal cell-growth promoter of skin

Country Status (1)

Country Link
JP (1) JP2006169149A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249051A (en) * 2005-03-14 2006-09-21 Kyoei Kagaku Kogyo Kk Fibroblast-activator and skin lotion containing the same
WO2009142320A1 (en) * 2008-05-22 2009-11-26 株式会社ロッテ Preventative and/or therapeutic agent against atopic dermatitis
JP2013107882A (en) * 2011-10-28 2013-06-06 Nippon Shinyaku Co Ltd Mangosteen extract
KR101299013B1 (en) * 2010-04-14 2013-08-23 동국대학교 산학협력단 Composition for Treatment of Pigmentation Disorders Containing the Extract of Mangosteen
US8853261B2 (en) 2008-01-21 2014-10-07 Laila Nutraceuticals Nutraceutical composition from Garcinia mangostana
JP2018520193A (en) * 2015-07-24 2018-07-26 山▲トゥン▼新薬開発股▲ふん▼有限公司 Use of mangosteen peel extract for the manufacture of skin disease treatment

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006249051A (en) * 2005-03-14 2006-09-21 Kyoei Kagaku Kogyo Kk Fibroblast-activator and skin lotion containing the same
US8853261B2 (en) 2008-01-21 2014-10-07 Laila Nutraceuticals Nutraceutical composition from Garcinia mangostana
WO2009142320A1 (en) * 2008-05-22 2009-11-26 株式会社ロッテ Preventative and/or therapeutic agent against atopic dermatitis
JPWO2009142320A1 (en) * 2008-05-22 2011-09-29 株式会社ロッテ Atopic dermatitis preventive and / or therapeutic agent
KR101299013B1 (en) * 2010-04-14 2013-08-23 동국대학교 산학협력단 Composition for Treatment of Pigmentation Disorders Containing the Extract of Mangosteen
JP2013107882A (en) * 2011-10-28 2013-06-06 Nippon Shinyaku Co Ltd Mangosteen extract
JP2017160255A (en) * 2011-10-28 2017-09-14 日本新薬株式会社 Mangosteen extract
JP2018520193A (en) * 2015-07-24 2018-07-26 山▲トゥン▼新薬開発股▲ふん▼有限公司 Use of mangosteen peel extract for the manufacture of skin disease treatment
EP3326637A4 (en) * 2015-07-24 2019-01-23 Xantho Biotechnology Co., Ltd. Use of mangosteen rind extract in preparation of medicine for treating skin diseases

Similar Documents

Publication Publication Date Title
KR102059453B1 (en) Cosmetic composition for enhancing function of skin barrier and anti wrinkle comprising agastache rugosa leaf extract
JP4425163B2 (en) Anti-aging cosmetics
JP2011088845A (en) Involucrin expression inhibitor
KR101839491B1 (en) Extraction Method of Houttuynia cordata Thunberg Extract and Cosmetic materials Using the same
JP2006241148A (en) Collagenase inhibitor and external preparation for skin for preventing aging
JP2006169149A (en) Epidermal basal cell-growth promoter of skin
JP2008303147A (en) External preparation for skin
FR2928549A1 (en) USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING
KR101303807B1 (en) Cosmetic composition having anti-aging effect
JP2006316029A (en) Endothelin-1 production inhibitor and melanin production inhibitor
JP2009269842A (en) External preparation for skin
JP4457133B2 (en) External preparation for skin and whitening agent
KR102552616B1 (en) Cosmetic composition for improving atopic dermatitis and dry skin containing Taraxacum Coreanum Phytoplacenta Culture Extract
JP4037836B2 (en) Hyaluronidase activity inhibitor
KR102206094B1 (en) Cosmetic composition comprising Pharbitidis Semen extract
KR102676799B1 (en) External Composition Comprising Natural Complex Extract for Improving Skin
JP2012041284A (en) Anti-aging agent, whitening agent, antioxidant, slimming agent and anti-inflammatory agent
JP7075298B2 (en) External skin preparation
JP2018177702A (en) Skin aging inhibitor containing hydrangea paniculata siebold extract as active ingredient and skin external preparation containing the same
JP4485154B2 (en) Skin external preparation for wrinkle prevention improvement
JPWO2008018133A1 (en) Moisturizer, cell activator, whitening agent, neutral fat accumulation inhibitor, antioxidant, and external preparation for skin
JP2009143833A (en) Extract of crude drug and skin external preparation having the same as active ingredient
JP2008074730A (en) Humectant, antiageing agent, whitening agent, anti-inflammatory agent, and, antioxidant
JP2004137166A (en) Skin care preparation for external use, cell activator and antioxidant
JP6920787B2 (en) Sebum secretion promoter and its use